A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia

[1]  B. Rounsaville,et al.  Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. , 2000, Addiction.

[2]  G. Alexopoulos,et al.  Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression , 1999, Biological Psychiatry.

[3]  Joel Gelernter,et al.  No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans , 1999, Biological Psychiatry.

[4]  P. Jatlow,et al.  Disulfiram effects on acute cocaine administration. , 1998, Drug and alcohol dependence.

[5]  K. Carroll,et al.  Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. , 1998, Addiction.

[6]  Kazuto Kobayashi,et al.  Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation , 1998, Human Genetics.

[7]  J. Krystal,et al.  295. Sensory gating and cocaine induced paranoia , 1998, Biological Psychiatry.

[8]  P. Jatlow,et al.  Chronic disulfiram treatment effects on intranasal cocaine administration: Initial results , 1998, Biological Psychiatry.

[9]  K. Kidd,et al.  Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). , 1997, American journal of medical genetics.

[10]  Allan Collins,et al.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies , 1997, Psychopharmacology.

[11]  M. Tsuang,et al.  How do genes influence marijuana use? The role of subjective effects. , 1997, Addiction.

[12]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Ramchand,et al.  Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals , 1996, Human Genetics.

[14]  K. Kidd,et al.  DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. , 1996, Alcoholism, clinical and experimental research.

[15]  S. Woods,et al.  Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans , 1995, Biological Psychiatry.

[16]  J. Long,et al.  An E-M algorithm and testing strategy for multiple-locus haplotypes. , 1995, American journal of human genetics.

[17]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[18]  Henry R. Kranzler,et al.  Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia , 1995, Neuropsychopharmacology.

[19]  S. Deutsch,et al.  The relationship between cocaine-induced paranoia and compulsive foraging: a preliminary report. , 1994, Addiction.

[20]  D. Kammen.  Principles and Practice of Psychopharmacotherapy , 1994 .

[21]  D. O'Connor,et al.  CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures. , 1994, The American journal of psychiatry.

[22]  M. Bell,et al.  Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. , 1994 .

[23]  Italo Biaggioni,et al.  Dopamine β-Hydroxylase Immunoreactivity in Human Cerebrospinal Fluid: Properties, Relationship to Central Noradrenergic Neuronal Activity and Variation in Parkinson's Disease and Congenital Dopamine β-Hydroxylase Deficiency , 1994 .

[24]  J. Krystal,et al.  Clinical Predictors of Self-Mutilation in Hospitalized Forensic Patients , 1994, The Journal of nervous and mental disease.

[25]  J. Gelernter,et al.  Mutational analysis of candidate genes in psychiatric disorders. , 1993, American journal of medical genetics.

[26]  N Risch,et al.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.

[27]  S. Povey,et al.  A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. , 1992, Human molecular genetics.

[28]  S. Satel,et al.  Cocaine-induced paranoia and psychosis proneness. , 1991, The American journal of psychiatry.

[29]  K. Brady,et al.  Cocaine-induced psychosis. , 1991, The Journal of clinical psychiatry.

[30]  J. Phillips,et al.  Linkage analysis of the human dopamine β-hydroxylase gene , 1991 .

[31]  K. Kidd,et al.  Sequence tagged site (STS) TaqI RFLP at dopamine beta-hydroxylase (DBH). , 1991, Nucleic acids research.

[32]  S. Southwick,et al.  Clinical features of cocaine-induced paranoia. , 1991, The American journal of psychiatry.

[33]  S. Southwick,et al.  Clinical features of cocaine induced paranoia. , 1991, NIDA research monograph.

[34]  K. Brady,et al.  Cocaine abuse among schizophrenic patients. , 1990, The American journal of psychiatry.

[35]  J. Brady.  Alcohol and the Writer , 1990 .

[36]  S. Channabasavanna,et al.  Serum dopamine‐β‐hydroxylase activity in clinical subtypes of depression , 1989 .

[37]  T Nagatsu,et al.  Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation. , 1989, Nucleic acids research.

[38]  R. Lewontin,et al.  On measures of gametic disequilibrium. , 1988, Genetics.

[39]  J. Mallet,et al.  Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. , 1988, Cytogenetics and cell genetics.

[40]  R. Elston,et al.  Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. , 1988, American journal of human genetics.

[41]  Z. Rihmer,et al.  Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression , 1986, Psychiatry Research.

[42]  G. Sedvall,et al.  Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. , 1986, Journal of psychiatric research.

[43]  D. O'Connor,et al.  Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. , 1983, Journal of hypertension.

[44]  J. Nurnberger,et al.  Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients , 1982, Psychoneuroendocrinology.

[45]  W. Bunney,et al.  Schizophrenia: dopamine beta-hydroxylase activity and treatment response. , 1982, Science.

[46]  D. Murphy,et al.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. , 1982, American journal of human genetics.

[47]  W. Lovenberg,et al.  Dopamine-beta-hydroxylase in the cerebrospinal fluid: relationship to disulfiram-induced psychosis. , 1979, Biological psychiatry.

[48]  R. Weinshilboum.  Serum dopamine beta-hydroxylase. , 1978, Pharmacological reviews.

[49]  B. Carroll,et al.  Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients. , 1976, Archives of general psychiatry.

[50]  R. Weinshilboum,et al.  Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. , 1976, American journal of human genetics.

[51]  F. Bloom,et al.  The biochemical basis of neuropharmacology, 2nd ed. , 1974 .